BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is an orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; disease or related to surgical procedures. The company develops its bone graft substitutes using its patented technology platform CERAMENT. Its major products include bone void filler and vancomycin-eluting synthetic bone substitutes. BoneSupport also carries out various pre-clinical product candidates intended to promote bone growth. The company markets its products through a network of distributors in Europe and North America. BoneSupport is headquartered in Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BoneSupport AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- BoneSupport AB Company Overview
- BoneSupport AB Company Snapshot
- BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview
- BoneSupport AB - Pipeline Analysis Overview
- Business Description
- BoneSupport AB - Key Facts
- BoneSupport AB - Major Products and Services
- BoneSupport AB Pipeline Products by Development Stage
- BoneSupport AB Ongoing Clinical Trials by Trial Status
- BoneSupport AB Pipeline Products Overview
- Cerament + Bisphosphonate
- Cerament + Bisphosphonate Product Overview
- Cerament + Bisphosphonates And BMP
- Cerament + Bisphosphonates And BMP Product Overview
- Cerament + BMP
- Cerament + BMP Product Overview
- Cerament + BMP 2
- Cerament + BMP 2 Product Overview
- Cerament Plus BMP And Stem Cells
- Cerament Plus BMP And Stem Cells Product Overview
- Cerament|G
- Cerament|G Product Overview
- Cerament|G Clinical Trial
- Gelatin/Cerament
- Gelatin/Cerament Product Overview
- BoneSupport AB - Key Competitors
- BoneSupport AB - Key Employees
- BoneSupport AB - Key Employee Biographies
- BoneSupport AB - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- BoneSupport AB, Recent Developments
- Jan 07, 2025: Cerament G and Cerament V Contributes to Improved Survival Rates
- Sep 26, 2024: Solario Study Meets Its Primary Endpoints - Bone Substitute With Local Antibiotics Enables Reduced Systemic Antibiotic Treatment
- Mar 22, 2024: BoneSupport Receives FDA 510(k) Clearance for Cerament|G
- Mar 19, 2024: BoneSupport Receives Additional 510(K) Clearance For Cerament Bone Void Filler
- Oct 24, 2022: Bonesupport’s CERAMENT G used in first U.S. patient cases
- Jun 16, 2022: MCRA assists BONESUPPORT with the first ever combination product DeNovo decision granted by the U.S. FDA
- May 26, 2022: BoneSupport receives Denovo clearance for Cerament|G
- Feb 28, 2022: Bonesupport delays within FDA postpones Cerament G De Novo decision
- Feb 28, 2022: BoneSupport : Delays within FDA postpones CERAMENT G De Novo decision
- Jan 13, 2022: BONESUPPORT signs distribution agreement with OrthoPediatrics
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview
- BoneSupport AB Pipeline Products by Equipment Type
- BoneSupport AB Pipeline Products by Indication
- BoneSupport AB Ongoing Clinical Trials by Trial Status
- BoneSupport AB, Key Facts
- BoneSupport AB, Major Products and Services
- BoneSupport AB Number of Pipeline Products by Development Stage
- BoneSupport AB Pipeline Products Summary by Development Stage
- BoneSupport AB Ongoing Clinical Trials by Trial Status
- BoneSupport AB Ongoing Clinical Trials Summary
- Cerament + Bisphosphonate - Product Status
- Cerament + Bisphosphonate - Product Description
- Cerament + Bisphosphonates And BMP - Product Status
- Cerament + Bisphosphonates And BMP - Product Description
- Cerament + BMP - Product Status
- Cerament + BMP - Product Description
- Cerament + BMP 2 - Product Status
- Cerament + BMP 2 - Product Description
- Cerament Plus BMP And Stem Cells - Product Status
- Cerament Plus BMP And Stem Cells - Product Description
- Cerament|G - Product Status
- Cerament|G - Product Description
- Cerament|G - A Post-Market Prospective Cohort Study on Subjects Receiving CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure
- Cerament|G - CERAMENT G Device Registry
- Cerament|G - Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones: Randomized Multicentre Study in the CRIOAc Network - CONVICTION Study
- Cerament|G - Post-market Study of Cerament V/G in Foot Osteomyelitis
- Gelatin/Cerament - Product Status
- Gelatin/Cerament - Product Description
- BoneSupport AB, Key Employees
- BoneSupport AB, Key Employee Biographies
- BoneSupport AB, Subsidiaries
- Glossary
- BoneSupport AB Pipeline Products by Equipment Type
- BoneSupport AB Pipeline Products by Development Stage
- BoneSupport AB Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Wright Medical Deutschland GmbH
- Promimic AB
- Graftys SA
- Embla Medical hf
- DOT GmbH
